SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Pluristem Therapeutics, Inc. (PSTI)

IMO..They Should Have Already Dosed The First Couple

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FDApproved Member Profile
Member Level 
Followed By 1
Posts 1,420
Boards Moderated 0
Alias Born 03/11/17
160x600 placeholder
Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at American Society of Hematology’s Annual Me... "GlobeNewswire Inc." - 12/7/2017 5:08:17 AM
Peer-Reviewed Article Published on Pluristem’s PLX-PAD Cells’ Mechanism of Action to Restore Blood Flow in Ischemic Tissu... "GlobeNewswire Inc." - 11/29/2017 7:00:00 AM
Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration - a Meaningful Asset Ahead of Upcoming Phase III Femoral N... "GlobeNewswire Inc." - 11/22/2017 7:00:00 AM
Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights "GlobeNewswire Inc." - 11/14/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2017 4:09:24 PM
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chron... "GlobeNewswire Inc." - 11/6/2017 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/31/2017 6:06:01 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2017 4:39:46 PM
Pluristem Announces Pricing of Public Offering of Common Stock on the Tel Aviv Stock Exchange "GlobeNewswire Inc." - 10/30/2017 2:45:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb "InvestorsHub NewsWire" - 10/30/2017 7:00:00 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) "Edgar (US Regulatory)" - 10/30/2017 6:06:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2017 6:05:22 AM
Pluristem Proposes to Launch a Public Offering of Common Stock on the Tel Aviv Stock Exchange After Concluding an Israeli Ins... "GlobeNewswire Inc." - 10/29/2017 5:49:59 PM
Following Approval of Israel’s Ministry of Health, Pluristem Extends its Trial of PLX-R18 to Treat Insufficient Hematopoiet... "GlobeNewswire Inc." - 10/26/2017 7:00:00 AM
Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Che... "GlobeNewswire Inc." - 10/23/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/19/2017 2:41:41 PM
FDA Grants Pluristem Orphan Drug Designation for Its PLX-R18 Cell Therapy as Treatment for Acute Radiation Syndrome "GlobeNewswire Inc." - 10/19/2017 7:30:00 AM
New Published Data Highlights the Potential of Pluristem's PLX Cells in Improving Cardiac Function in Diabetes "GlobeNewswire Inc." - 10/16/2017 7:00:00 AM
$7.9 Million Granted to nTRACK Collaborative Project Designed to Study Pluristem’s PLX-PAD Cells "GlobeNewswire Inc." - 10/2/2017 7:00:00 AM
Pluristem Receives Positive Feedback from FDA and EMA as Company Prepares for Phase III Trial of PLX-PAD to Support Recovery ... "GlobeNewswire Inc." - 9/26/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/18/2017 4:01:56 PM
U.S. FDA Grants Fast Track Designation to Pluristem's PLX-PAD for the Treatment of Critical Limb Ischemia (CLI) "GlobeNewswire Inc." - 9/18/2017 7:00:00 AM
Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regene... "GlobeNewswire Inc." - 9/13/2017 7:00:00 AM
Pluristem Reports Fourth Quarter and Fiscal 2017 Corporate and Financial Highlights "GlobeNewswire Inc." - 9/11/2017 8:17:04 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/7/2017 4:12:17 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist